Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016–2017 epidemic season: a systematic review of seven Italian reports

Table 3 Summary table for the TIPNet data

Season	Population composition (TIPNet), n	Preterm and no comorbidity, n (%)	Full term and comorbidity, n (%)	Preterm and comorbidity, n (%)	Length of stay (mean number of days)
Season	Population composition (TIPNet), n	Preterm and no comorbidity, n (%)	Full term and comorbidity, n (%)	Preterm and comorbidity, n (%)	Without chronic disease	With chronic disease	Preterm	Full term
2014–2015	88	16 (18)	4 (4.5)	3 (3)	6.2	13	14	5
2015–2016	115	12 (10)	8 (7)	3 (3)
2016–2017	111	35 (32)	14 (13)	6 (5)

ALRI Acute Lower Respiratory Infections, RSV respiratory syncytial virus, TIPNet Italian Network of Pediatric Intensive Care Units, wGA weeks of gestational age

ISSN: 1824-7288